Skip to main content

Table 2 Comparison between the two studied groups according to HCC treatment

From: Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence

HCC treatment modalities

Group I (n = 50), no. (%)

Group II (n = 50), no. (%)

χ2

p

Hepatic resection

11 (22%)

12 (24%)

1.002

0.182

RFA

27 (54%)

35 (70%)

3.549

0.420

LDLT

10 (20%)

0 (0.0%)

7.696*

p = 0.006*

Alcohol injection

2 (4.0%)

3 (6.0%)

1.010

p = 1.000

  1. RFA radiofrequency ablation, LDLT living donor liver transplant
  2. *Statistically significant at p ≤ 0.05